stockrowBioXcel Therapeutics, Inc. (BTAIQ) vs Petros Pharmaceuticals, Inc. (PTPI)
- BioXcel Therapeutics, Inc. BTAIQ 0.01 0.00%
- Petros Pharmaceuticals, Inc. PTPI 0.00 NaN
BioXcel Therapeutics, Inc. and Petros Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. BioXcel Therapeutics, Inc. is the larger, with a market value of $2.3M against $1.0M — 2.2× the size. Petros Pharmaceuticals, Inc. grew revenue faster over the last twelve months: −12.2% against −14.5%. Petros Pharmaceuticals, Inc. has the higher net margin (0.00% vs −9,549.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Petros Pharmaceuticals, Inc. leads on 10 and BioXcel Therapeutics, Inc. on 4.
Valuation
Profitability
| Metric | BTAIQ | PTPI | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 53.10% | 118.32% | 53.51% |
| Operating margin | (6,054.72%) | 0.00% | 0.00% |
| Net margin | (9,549.87%) | 0.00% | (2.45%) |
| Free cash flow margin | (6,860.38%) | 0.00% | 0.00% |
| Return on equity | 63.52% | (710.28%) | (0.80%) |
| Return on assets | (259.62%) | (334.15%) | (1.67%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack